The CheckMate 057 study showed that prolonged OS with nivolumab treatment was correlated with higher levels of tumor PD-L1 expression, but treatment efficacy was also reported in patients with less than 1% PD-L1 expressions13. The gene discussed is CD274; the disease is neoplasm.